Skip to content

Emergency Room Firearm and Medication Safety Intervention

Development and Testing of a Veteran-Centered Lethal Means Safety Suicide Prevention Intervention (CDA 19-076)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04797221
Enrollment
28
Registered
2021-03-15
Start date
2021-07-01
Completion date
2023-02-16
Last updated
2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Firearm Injury, Overdose, Suicide

Keywords

suicide

Brief summary

Seventeen United States Veterans die by suicide each day. Nearly three-fourths of those Veterans die from firearm injury or poisoning, and many seek care in VA Emergency Departments (ED) prior to suicide attempts. In 2019, the VA began screening all Veterans seeking ED care for increased suicide risk. Interventions that promote firearm and medication safety are recommended for Veterans identified as at-risk. The investigators work will provide important information that will aid the development and testing of such an intervention for Veterans who seek care in VA EDs. The investigators will interview at-risk Veterans who recently sought VA ED care to identify factors relevant to developing the intervention, and work with Veterans and VA healthcare staff to develop and test an intervention.

Detailed description

Veterans will be recruited from the Rocky Mountain Regional VA Medical Center (RMRVAMC) ED who are identified as having elevated suicide risk by VHA's new suicide risk screening initiative. All Veterans visiting VHA EDs are screened using an eight-item version of the Columbia Suicide Severity Rating Scale (C-SSRS) Screener, a valid predictor of future suicidal behavior. The C-SSRS Screener assesses suicide risk using eight items about recent suicidal ideation and intent, preparatory behaviors, and action. Deductive and inductive content analysis of qualitative interviews will occur in parallel with recruitment, and participants will be recruited until thematic saturation is achieved. Veterans' visits (approx. 90 minutes) will be scheduled at their preferred times at RMRVAMC within two weeks of discharge from the ED. Sociodemographic and military service data will be collected using the Rocky Mountain Mental Illness Research, Education, and Clinical Center (MIRECC) Demographics Survey. During this visit, individuals will participate in qualitative interviews to identify contextual factors that may inform development of VA-based lethal means safety interventions.

Interventions

None listed

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Veteran * Recent Emergency Room care * Screen positive for elevated suicide risk

Exclusion criteria

* Severe cognitive impairment * Lack decisional capacity * Unable to provide informed consent * Lack reliable phone access * Admitted to the hospital

Design outcomes

Primary

MeasureTime frameDescription
Qualitative Theme Among 28 Patients on Perspectives on Lethal Means InterventionsbaselinePerspectives on VA-based interventions that aim to reduce access to firearms and medications.

Countries

United States

Participant flow

Participants by arm

ArmCount
Study Group
28 Veterans who were recently discharged from a VHA emergency care. Veteran participants were: \>18 years of age, had access to firearms and/or medications at home, and were determined to be at elevated suicide risk based on the presence of suicide risk factors, including screening positive for having elevated suicide risk at the time of admission via the Columbia Suicide Severity Rating Scale Screener. Veterans were excluded if they were critically ill (intensive care unit requirements), are severely cognitively impaired, or had severe psychiatric symptoms that would preclude study participation.
28
Total28

Baseline characteristics

CharacteristicStudy Group
Age, Continuous55.9 years
STANDARD_DEVIATION 14.9
Race/Ethnicity, Customized
Race / Ethnicity
African American / Black
1 Participants
Race/Ethnicity, Customized
Race / Ethnicity
missing
1 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Other
2 Participants
Race/Ethnicity, Customized
Race / Ethnicity
White
24 Participants
Region of Enrollment
United States
28 Participants
Sex/Gender, Customized
Gender
Cisgender female
4 Participants
Sex/Gender, Customized
Gender
Cisgender male
24 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 28
serious
Total, serious adverse events
0 / 28

Outcome results

Primary

Qualitative Theme Among 28 Patients on Perspectives on Lethal Means Interventions

Perspectives on VA-based interventions that aim to reduce access to firearms and medications.

Time frame: baseline

ArmMeasureGroupValue (NUMBER)
Study GroupQualitative Theme Among 28 Patients on Perspectives on Lethal Means InterventionsAcceptability26 participants
Study GroupQualitative Theme Among 28 Patients on Perspectives on Lethal Means InterventionsUncertainty about intent and efficacy20 participants
Study GroupQualitative Theme Among 28 Patients on Perspectives on Lethal Means InterventionsCost and convenience are critical24 participants
Study GroupQualitative Theme Among 28 Patients on Perspectives on Lethal Means InterventionsUncertainty regarding engaging other people in interventions14 participants
Study GroupQualitative Theme Among 28 Patients on Perspectives on Lethal Means InterventionsInfluence of prior opioid exposure12 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026